Discover how cfDNA fragmentome tests could help detect liver disease early and track health. Learn more about this emerging ...

Leerink Global Healthcare Conference 2026 March 11, 2026 8:00 AM EDTCompany ParticipantsSam Samad - Executive VP ...

Built on groundbreaking research from Israel ’s Weizmann Institute of Science, Promise Bio developed the first cloud-based platform for broad epiproteomics, helping researchers uncover disease ...

Advancing the Discovery of Novel Therapies and Building an Integrated Drug Discovery Platform by Combining PPI Science with AI - ...

AI Nose deployment into front-end wafer fabrication facilities marks a critical validation step in semiconductor manufacturing environmentsRecurring revenue visibility strengthens as AI Nose deploymen ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from animal testing toward new approaches. One year later, much speculation ...

Artificial intelligence is rapidly transforming health care. AI systems can now detect diabetic eye disease from retinal photos and analyze CT images for signs of early-stage lung cancers and stroke.

The care of immunocompromised adults with acute respiratory failure (ARF) remains one of the greatest challenges of intensive care medicine.1 Management of these patients is challenging because ...

Objective A panel of antibodies against three antigens, University Hasselt (UH)-rheumatoid arthritis (RA).305, 318 and 329, has been associated with lack of response to first-line therapy in the Care ...

PECOTA, which stands for Player Empirical Comparison and Optimization Test Algorithm, is BP’s proprietary system that projects player and team performance PECOTA is a system that takes a player’s past ...